News

Deal Announcements

Meditope Biosciences Bags New Venture Capital Equity

Tuesday, October 13, 2015 5:48:00 AM PDT | VentureDeal
   Pasadena, California  --  Biotechnology company Meditope Biosciences has secured $1.6 million in new venture capital equity funding, according to an SEC regulatory filing.

Meditope has developed technology that "is capable of turning any monoclonal antibody into a proprietary, site-specific Lego-like system."

The resulting system is able to attach and detach drugs to antibodies without the need for chemical conjugation.

Investors in the financing were not disclosed, nor was how the company intends to use the funding proceeds.

Meditope is still seeking $3.4 million in additional equity investment, according to the filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1